Detalles de la búsqueda
1.
A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancer.
Cancer
; 128 Suppl 11: 2209-2223, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35536015
2.
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer.
BMC Cancer
; 22(1): 407, 2022 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35421940
3.
Treatment patterns and overall survival in HER2+ metastatic breast cancer at US community oncology practices.
Future Oncol
; 18(7): 849-858, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34756117
4.
"Nobody Will Tell You. You've Got to Ask!": An Examination of Patient-Provider Communication Needs and Preferences among Black and White Women with Early-Stage Breast Cancer.
Health Commun
; 36(11): 1331-1342, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32336140
5.
A qualitative exploration of race-based differences in social support needs of diverse women with breast cancer on adjuvant therapy.
Psychooncology
; 28(3): 570-576, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30636189
6.
Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast Cancer.
J Natl Compr Canc Netw
; 15(3): 284-287, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28275030
7.
Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer Treated in the US Community Setting.
JCO Oncol Pract
; 20(3): 370-377, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194619
8.
Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research.
Contemp Clin Trials
; 137: 107416, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38109966
9.
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.
J Clin Oncol
; : JCO2400662, 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38759122
10.
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.
Clin Cancer Res
; 30(4): 767-778, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38060199
11.
Mobile application to support oncology patients during treatment on patient outcomes: Evidence from a randomized controlled trial.
Cancer Med
; 12(5): 6190-6199, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36258654
12.
Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor-Positive Breast Cancer.
Cancer Epidemiol Biomarkers Prev
; 32(2): 167-174, 2023 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36166516
13.
Silent suffering: the impact of sexual health challenges on patient-clinician communication and adherence to adjuvant endocrine therapy among Black women with early-stage breast cancer.
J Cancer Surviv
; 2023 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114711
14.
27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study.
Clin Lung Cancer
; 24(2): 137-144, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36564297
15.
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
NPJ Breast Cancer
; 9(1): 41, 2023 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210417
16.
Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events.
Clin Lung Cancer
; 23(8): 686-693, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36050243
17.
Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer.
JAMA Netw Open
; 5(8): e2225485, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35947386
18.
Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.
Clin Breast Cancer
; 21(6): 539-551, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34154926
19.
Development of a Prognostic Factor Index Among Women With HR+/HER2- Metastatic Breast Cancer in a Community Oncology Setting.
Clin Breast Cancer
; 21(4): 317-328.e7, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33678566
20.
THRIVE intervention development: using participatory action research principles to guide a mHealth app-based intervention to improve oncology care.
J Hosp Manag Health Policy
; 52021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34308256